NK inhibitory-receptor blockade for purging of leukemia: Effects on hematopoietic reconstitution

Crystal Y. Koh, Arati Raziuddin, Lisbeth A. Welniak, Bruce R. Blazar, Michael Bennett, William J. Murphy

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

One of the obstacles of BMT that limits its efficacy is failure to eradicate the original tumor. The incidence of tumor relapse is particularly high after autologous BMT. Natural killer (NK) cells comprise various subsets that can express inhibitory receptors for MHC class I determinants. We have recently demonstrated that blockade of NK-cell inhibitory receptors can augment antitumor effects in vitro and in vivo. However, breakdown of tolerance and autoreactivity may occur as a result of the inhibition of NK-cell inactivation to self MHC determinants. We have utilized F(ab′)2 fragments of monoclonal antibody, 5E6, against Ly49C/I inhibitory receptors, which are expressed on 35% to 60% of NK cells in H2b strains of mice and are specific for H2Kb, to investigate the effect of inhibitory-receptor blockade on syngeneic bone marrow cell (BMC) and tumor cell growth. We show that treatment of interleukin 2-activated C57BL/6 (B6, H2b) SCID-mouse NK cells with 5E6 F(ab′)2 fragments during 48-hour coculture resulted in autoreactivity against syngeneic BMCs as demonstrated by suppression of myeloid reconstitution on day 14 post-BMT. However, this suppressive effect was transient and normalized by day 21 post-BMT. In contrast, blockade of inhibitory receptors during 24-hour coculture had no adverse effects on myeloid reconstitution after BMT. Furthermore, under the same coculture conditions, NK cell-mediated purging of C1498 leukemia cells contaminating syngeneic BMCs was more effective with inhibitory-receptor blockade, leading to a significantly higher proportion of animals with long-term survival compared to the control recipients. These results demonstrate that short-term in vitro blockade of inhibitory receptors can augment antitumor activity without long-term inhibitory effects on BMCs and thus may be of potential use in the purging of contaminating tumor cells prior to autologous BMT.

Original languageEnglish
Pages (from-to)17-25
Number of pages9
JournalBiology of Blood and Marrow Transplantation
Volume8
Issue number1
DOIs
Publication statusPublished - 2002

Fingerprint

KIR Receptors
Natural Killer Cells
Leukemia
Coculture Techniques
Neoplasms
Natural Killer Cell Receptors
SCID Mice
Bone Marrow Cells
Interleukin-2
Monoclonal Antibodies
Recurrence
Incidence
Growth

Keywords

  • BMT
  • Bone marrow cells
  • Engraftment
  • Hematopoietic reconstitution
  • Leukemia
  • Ly49 inhibitory receptors
  • NK inhibitory-receptor blockade
  • Purging

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

NK inhibitory-receptor blockade for purging of leukemia : Effects on hematopoietic reconstitution. / Koh, Crystal Y.; Raziuddin, Arati; Welniak, Lisbeth A.; Blazar, Bruce R.; Bennett, Michael; Murphy, William J.

In: Biology of Blood and Marrow Transplantation, Vol. 8, No. 1, 2002, p. 17-25.

Research output: Contribution to journalArticle

Koh, Crystal Y. ; Raziuddin, Arati ; Welniak, Lisbeth A. ; Blazar, Bruce R. ; Bennett, Michael ; Murphy, William J. / NK inhibitory-receptor blockade for purging of leukemia : Effects on hematopoietic reconstitution. In: Biology of Blood and Marrow Transplantation. 2002 ; Vol. 8, No. 1. pp. 17-25.
@article{6fad98e6c9b844788c1e5f9f34821809,
title = "NK inhibitory-receptor blockade for purging of leukemia: Effects on hematopoietic reconstitution",
abstract = "One of the obstacles of BMT that limits its efficacy is failure to eradicate the original tumor. The incidence of tumor relapse is particularly high after autologous BMT. Natural killer (NK) cells comprise various subsets that can express inhibitory receptors for MHC class I determinants. We have recently demonstrated that blockade of NK-cell inhibitory receptors can augment antitumor effects in vitro and in vivo. However, breakdown of tolerance and autoreactivity may occur as a result of the inhibition of NK-cell inactivation to self MHC determinants. We have utilized F(ab′)2 fragments of monoclonal antibody, 5E6, against Ly49C/I inhibitory receptors, which are expressed on 35{\%} to 60{\%} of NK cells in H2b strains of mice and are specific for H2Kb, to investigate the effect of inhibitory-receptor blockade on syngeneic bone marrow cell (BMC) and tumor cell growth. We show that treatment of interleukin 2-activated C57BL/6 (B6, H2b) SCID-mouse NK cells with 5E6 F(ab′)2 fragments during 48-hour coculture resulted in autoreactivity against syngeneic BMCs as demonstrated by suppression of myeloid reconstitution on day 14 post-BMT. However, this suppressive effect was transient and normalized by day 21 post-BMT. In contrast, blockade of inhibitory receptors during 24-hour coculture had no adverse effects on myeloid reconstitution after BMT. Furthermore, under the same coculture conditions, NK cell-mediated purging of C1498 leukemia cells contaminating syngeneic BMCs was more effective with inhibitory-receptor blockade, leading to a significantly higher proportion of animals with long-term survival compared to the control recipients. These results demonstrate that short-term in vitro blockade of inhibitory receptors can augment antitumor activity without long-term inhibitory effects on BMCs and thus may be of potential use in the purging of contaminating tumor cells prior to autologous BMT.",
keywords = "BMT, Bone marrow cells, Engraftment, Hematopoietic reconstitution, Leukemia, Ly49 inhibitory receptors, NK inhibitory-receptor blockade, Purging",
author = "Koh, {Crystal Y.} and Arati Raziuddin and Welniak, {Lisbeth A.} and Blazar, {Bruce R.} and Michael Bennett and Murphy, {William J.}",
year = "2002",
doi = "10.1053/bbmt.2002.v8.pm11846352",
language = "English",
volume = "8",
pages = "17--25",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - NK inhibitory-receptor blockade for purging of leukemia

T2 - Effects on hematopoietic reconstitution

AU - Koh, Crystal Y.

AU - Raziuddin, Arati

AU - Welniak, Lisbeth A.

AU - Blazar, Bruce R.

AU - Bennett, Michael

AU - Murphy, William J.

PY - 2002

Y1 - 2002

N2 - One of the obstacles of BMT that limits its efficacy is failure to eradicate the original tumor. The incidence of tumor relapse is particularly high after autologous BMT. Natural killer (NK) cells comprise various subsets that can express inhibitory receptors for MHC class I determinants. We have recently demonstrated that blockade of NK-cell inhibitory receptors can augment antitumor effects in vitro and in vivo. However, breakdown of tolerance and autoreactivity may occur as a result of the inhibition of NK-cell inactivation to self MHC determinants. We have utilized F(ab′)2 fragments of monoclonal antibody, 5E6, against Ly49C/I inhibitory receptors, which are expressed on 35% to 60% of NK cells in H2b strains of mice and are specific for H2Kb, to investigate the effect of inhibitory-receptor blockade on syngeneic bone marrow cell (BMC) and tumor cell growth. We show that treatment of interleukin 2-activated C57BL/6 (B6, H2b) SCID-mouse NK cells with 5E6 F(ab′)2 fragments during 48-hour coculture resulted in autoreactivity against syngeneic BMCs as demonstrated by suppression of myeloid reconstitution on day 14 post-BMT. However, this suppressive effect was transient and normalized by day 21 post-BMT. In contrast, blockade of inhibitory receptors during 24-hour coculture had no adverse effects on myeloid reconstitution after BMT. Furthermore, under the same coculture conditions, NK cell-mediated purging of C1498 leukemia cells contaminating syngeneic BMCs was more effective with inhibitory-receptor blockade, leading to a significantly higher proportion of animals with long-term survival compared to the control recipients. These results demonstrate that short-term in vitro blockade of inhibitory receptors can augment antitumor activity without long-term inhibitory effects on BMCs and thus may be of potential use in the purging of contaminating tumor cells prior to autologous BMT.

AB - One of the obstacles of BMT that limits its efficacy is failure to eradicate the original tumor. The incidence of tumor relapse is particularly high after autologous BMT. Natural killer (NK) cells comprise various subsets that can express inhibitory receptors for MHC class I determinants. We have recently demonstrated that blockade of NK-cell inhibitory receptors can augment antitumor effects in vitro and in vivo. However, breakdown of tolerance and autoreactivity may occur as a result of the inhibition of NK-cell inactivation to self MHC determinants. We have utilized F(ab′)2 fragments of monoclonal antibody, 5E6, against Ly49C/I inhibitory receptors, which are expressed on 35% to 60% of NK cells in H2b strains of mice and are specific for H2Kb, to investigate the effect of inhibitory-receptor blockade on syngeneic bone marrow cell (BMC) and tumor cell growth. We show that treatment of interleukin 2-activated C57BL/6 (B6, H2b) SCID-mouse NK cells with 5E6 F(ab′)2 fragments during 48-hour coculture resulted in autoreactivity against syngeneic BMCs as demonstrated by suppression of myeloid reconstitution on day 14 post-BMT. However, this suppressive effect was transient and normalized by day 21 post-BMT. In contrast, blockade of inhibitory receptors during 24-hour coculture had no adverse effects on myeloid reconstitution after BMT. Furthermore, under the same coculture conditions, NK cell-mediated purging of C1498 leukemia cells contaminating syngeneic BMCs was more effective with inhibitory-receptor blockade, leading to a significantly higher proportion of animals with long-term survival compared to the control recipients. These results demonstrate that short-term in vitro blockade of inhibitory receptors can augment antitumor activity without long-term inhibitory effects on BMCs and thus may be of potential use in the purging of contaminating tumor cells prior to autologous BMT.

KW - BMT

KW - Bone marrow cells

KW - Engraftment

KW - Hematopoietic reconstitution

KW - Leukemia

KW - Ly49 inhibitory receptors

KW - NK inhibitory-receptor blockade

KW - Purging

UR - http://www.scopus.com/inward/record.url?scp=0036170844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036170844&partnerID=8YFLogxK

U2 - 10.1053/bbmt.2002.v8.pm11846352

DO - 10.1053/bbmt.2002.v8.pm11846352

M3 - Article

C2 - 11846352

AN - SCOPUS:0036170844

VL - 8

SP - 17

EP - 25

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 1

ER -